U.S. markets open in 4 hours 25 minutes

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - NYSE American Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
0.8639+0.0029 (+0.34%)
Al cierre: 03:58PM EDT
0.8800 +0.02 (+1.86%)
Fuera de horario: 05:59PM EDT

Xtant Medical Holdings, Inc.

664 Cruiser Lane
Belgrade, MT 59714
United States
406 388 0480
https://www.xtantmedical.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo207

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Sean E. BrownePresident, CEO & Director1.29MN/D1966
Mr. Mark A. SchallenbergerChief Operations Officer778.42kN/D1986
Mr. Kevin D. BrandtSenior VP & Chief Commercial Officer658.03kN/D1966
Mr. Scott C. NeilsChief Financial Officer517.86kN/D1984
Ms. Catherine LundyVice President of Human ResourcesN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.

Gestión corporativa

La calificación ISS Governance QuickScore de Xtant Medical Holdings, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.